Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
BNP Paribas Primary New Issues: STAB Notice - NO STAB - UGI INTERNATIONAL LLC
-
Cabaletta Bio Reports First Quarter 2026 Financial Results and Provides Business Update
-
Summit Royalties Commences Trading on OTCQX; Other Corporate Updates
-
Guardian Capital Announces May 2026 Cash Distributions for Guardian Capital ETFs
-
Evolve Royalties Announces Binding Letter of Intent to Acquire a Royalty on the Sunnyside Project in Arizona, USA
-
Invivyd Reports First Quarter 2026 Financial Results and Recent Business Highlights
-
ASHA and Hilarity for Charity Collaborate in Free, Online Event for Dementia Caregivers on May 20
-
Chicago Atlantic BDC, Inc. Declares $0.34 Cash Dividend for Second Quarter 2026
-
Aveanna Healthcare Holdings Announces First Quarter Financial Results and Revised 2026 Guidance
-
Hyperion DeFi Reports 1Q 2026 Financial Results with Record Net Income and Raises Guidance for Full Year 2026
-
Premier American Uranium Commences 100,000 ft Exploration Drilling Program at the Kaycee ISR Uranium Project, Wyoming
-
Barrick Announces Election of Directors
-
Unified Mechanical Group Launches as Full-Service Commercial and Industrial HVAC Contractor in Southern California
-
Wendy’s Canada Brings Fresh Flavours to Menus Nationwide with New Strawberry Salad, Watermelon Lemonade and More
-
Calian Reports Record Results for the Second Quarter of Fiscal 2026
-
NETSOL Technologies reports record quarterly revenue and 13% year-over-year growth in Q3 fiscal 2026
-
Legence Reports First Quarter 2026 Financial Results
-
Arianne Phosphate Successfully Produces Phosphoric Acid on a Continuous Basis
-
Aya Gold & Silver Reports Q1-2026 Results with Record Revenue and Cash Flow
-
ESW Launches Microsoft 365 AI Readiness Audits and Roadmaps to Help Companies Move Faster With AI
-
Pelthos Therapeutics Announces First Quarter 2026 Financial Results
-
Chicago Atlantic BDC, Inc. Reports First Quarter 2026 Financial Results
-
Cabaletta Bio Presents Preconditioning-free Clinical Data and Automated Manufacturing Translational Data for Rese-cel at ASGCT 2026 Annual Meeting
-
illumin and Cint make brand measurement immediate and actionable in programmatic advertising
-
Climb Bio to Present New Budoprutug Clinical Data at European Hematology Association (EHA) 2026 Congress
-
Larimar Therapeutics Reports First Quarter 2026 Financial and Business Update
-
Solo Brands, Inc. Announces Fiscal 2026 First Quarter Results
-
American Shared Hospital Services Reports First Quarter 2026 Financial Results
-
Americold Delivering Centralized Cold Chain Logistics Solutions to PLUS in the Netherlands
-
Deep Isolation Nuclear, Inc. Reports Operational and Financial Results for the First Quarter of 2026
-
EyePoint Announces Third Consecutive Positive DSMC Recommendation for Phase 3 Wet AMD Trials for DURAVYU™, Building Confidence Ahead of Mid-2026 Topline Data
-
Bitdeer Reports Unaudited Financial Results for the First Quarter of 2026
-
OTC Markets Group Welcomes Summit Royalties Ltd to OTCQX
-
Fiserv Launches agentOS: The Operating System for Agentic AI in Banking
-
OTC Markets Group Welcomes PRINCE SILVER CORP to OTCQX
-
VTEM Airborne Survey is Underway on VR’s Empire Copper-Nickel-PGM Project in Ontario
-
GH Research Reports First Quarter 2026 Financial Results and Provides Business Update
-
CAMP4 Therapeutics to Present New Preclinical Data Demonstrating CMP-002 Improves Seizure Threshold and Severity in a Model of SYNGAP1-Related Disorder
-
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report First Quarter 2026 Financial Results and Provide Corporate Update
-
XORTX Announces US$5 Million Public Offering
-
Autolus Therapeutics Reports First Quarter 2026 Financial Results and Business Updates
-
Talisker Announces 2026 Mineral Resource Statement for the Bralorne Gold Project
-
Boralex reports higher operating income and the addition of new growth projects in the first quarter of 2026
-
Synack’s Analysis of 11,000+ Vulnerabilities Reveals Top Weaknesses Attackers Are Weaponizing Today
-
Tiziana Reports Reduced Brain Inflammation in Multiple System Atrophy Patients Treated with Intranasal Foralumab
-
Profound to Showcase TULSA-PRO®, the TULSA Procedure™ and the Future of iMRI at AUA2026
-
Corvus Pharmaceuticals Presents Soquelitinib Phase 1 Atopic Dermatitis Data at the Society for Investigative Dermatology (SID) Annual Meeting
-
Destination XL Group, Inc. to Announce First Quarter 2026 Financial Results on Thursday, May 28, 2026
-
Concorde International Group Secures Multi-Year Contracts Worth Over US$10 Million for Integrated Security Solutions in Singapore
-
POET Technologies and Lumilens Advance Wafer-Level Photonic Integration for Next-Generation AI Optical Networks

